Meta Growth (META) Stock Price, News & Analysis

Company Overview

Meta Growth Corp. operates as a recreational cannabis retailer in Canada. It operates recreational retail cannabis stores under the Meta Cannabis Supply Co. and NewLeaf Cannabis banners to sell cannabis and cannabis related products. The company was formerly known as National Access Cannabis Corp. and changed its name to Meta Growth Corp. in February 2020. Meta Growth Corp. was incorporated in 2014 and is based in Etobicoke, Canada. As of November 18, 2020, Meta Growth Corp. operates as a subsidiary of High Tide Inc.

Key Stats

• Today's Range: C$0.14 to C$0.14
• 50-Day Range: C$0.14 to C$0.14
• 52-Week Range: C$0.07 to C$0.41
• Volume: 58,900 shs
• Average Volume: 560,298 shs
• Market Capitalization: C$33.14 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

META Stock Analysis - Frequently Asked Questions

How have META shares performed this year?

Meta Growth's stock was trading at C$0.14 on January 1st, 2024. Since then, META shares have increased by 0.0% and is now trading at C$0.14.
View the best growth stocks for 2024 here.

How do I buy shares of Meta Growth?

Shares of META stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What other stocks do shareholders of Meta Growth own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Meta Growth investors own include NVIDIA (NVDA), Plug Power (PLUG), Advanced Micro Devices (AMD), FuelCell Energy (FCEL), Workhorse Group (WKHS), Fortress Biotech (FBIO) and Ovid Therapeutics (OVID).

Industry, Sector and Symbol

• Stock Exchange: CVE
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: Computer Software
• Current Symbol: CVE:META
• CUSIP: N/A
• CIK: N/A
• Web: www.metagrowth.com
• Phone: 647-689-6382
• Fax: N/A
• Employees: 86,500
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 1,112.33
• Current Ratio: 4.29
• Quick Ratio: 2.94

Sales & Book Value

• Annual Sales: C$60.96 million
• Price / Sales: 0.54
• Cash Flow: C$0.06 per share
• Price / Cash Flow: 2.33
• Book Value: C$0.02 per share
• Price / Book: 8.24

Miscellaneous

• Outstanding Shares: 236,680,000
• Free Float: N/A
• Market Cap: C$33.14 million
• Optionable: Not Optionable
• Beta: N/A